An excellent overview of nanomedicine from the European Union (EU).  It describes perfectly technologies being developed by Peptineo.  Peptineo, a nanotechnology company based in Albuquerque, New Mexico, is currently developing commercial technologies around the use of novel polymeric materials for drug delivery applications.  In particular, one material under development, acetalated dextran (Ac-DEX), has recently been used as the basis for a novel vaccine under the direction of noted academic researchers and the US Department of Defense, Defense Advanced Research Projects Agency (DARPA).  Ac-DEX is also being reviewed for applications in which it could facilitate the re-introduction of failed late-stage drug candidates into the regulatory approval process.  In this case, it is anticipated that through its ability to precisely control the release of active pharmaceutical ingredients (APIs), Ac-DEX will offer a significantly better safety profile in numerous therapeutic applications.  Peptineo is looking forward to sharing details about Ac-DEX based materials soon